Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c

Alto Neuroscience, Inc. (NYSE: ANRO) reported Q2 EPS of ($0.65), $0.10 better than the analyst estimate of ($0.75).

For earnings history and earnings-related data on Alto Neuroscience, Inc. (ANRO) click here.

You May Also Be Interested In

• Alto Neuroscience (ANRO) PT Raised to $55 at H.C. Wainwright
• Viking Holdings (VIK) PT Raised to $121 at UBS Ahead of Q2 Earnings
• Lowe's slashes full-year sales outlook amid DIY spending pressure